CD38 and plasma cell myeloma: In a recent study, Pape et al. reported the synthesis of a fluorochrome-conjugated nanobody that recognized a distinct non-overlapping epitope of CD38 allowing for specific detection of myeloma cells under daratumumab therapy [14].